Pharmidex attending ISNTD 2016
May 25, 2016
Pharmidex play a collaborative role in supporting Professor Simon Croft (London School of Hygiene & Tropical Medicine) presentation of Academia industry joint development models.
Pharmidex will be attending The International Society for Neglected Tropical Disease ISNTD d³ 2016
Pharmidex are proud to play a collaborative role in supporting Professor Simon Croft (London School of Hygiene & Tropical Medicine) presentation of Academia industry joint development models. May 25-26th 2016 Wellcome Trust London.
For more Information please see the following link:
http://www.isntdd3.com/
We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.
Pharmidex is pleased to share that Ash Alavijeh , our Head of Operations, will be attending the Life Sciences Wallonia Business Forum this evening at the Residence of the Belgian Ambassador. Hosted by the Economic Counsellor of Belgium-Wallonia Investment & Trade, the event brings together leading organisations across the European life sciences sector to explore how Wallonia supports international growth both financially and strategically. We look forward to connecting with international partners and exploring opportunities for collaboration and innovation in the European life sciences ecosystem.
Pharmidex is proud to sponsor the SMR meeting Target Identification and Validation in Drug Discovery
We’re excited that Janette Dalay Robertson (Business Development Manager) and Ian Knowles (Head of Respiratory) will attend, eager to meet attendees, share ideas and explore new collaborations to advance drug discovery and development. At Pharmidex , we know robust target validation is key to successful therapeutics. Our expertise in biomarker analysis, histology, in vivo models, and autoimmune disease research supports innovation across translational medicine.
